FOLLOWUS
1. School of Preclinical Medicine, Beijing University of Chinese Medicine,Beijing,China
2. Center of Scientific Experiment, Beijing University of Chinese Medicine,Beijing,China
纸质出版日期:2018,
网络出版日期:2015-4-24,
Scan for full text
Kong, H., Wang, Xq., Wang, Qg. et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction (葛根芩连汤) in Mice., Chin. J. Integr. Med. 24, 525–530 (2018). https://doi.org/10.1007/s11655-015-1973-0
Hui Kong, Xue-qian Wang, Qing-guo Wang, et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction (葛根芩连汤) in Mice[J]. Chinese Journal of Integrative Medicine, 2018,24(7):525-530.
Kong, H., Wang, Xq., Wang, Qg. et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction (葛根芩连汤) in Mice., Chin. J. Integr. Med. 24, 525–530 (2018). https://doi.org/10.1007/s11655-015-1973-0 DOI:
Hui Kong, Xue-qian Wang, Qing-guo Wang, et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction (葛根芩连汤) in Mice[J]. Chinese Journal of Integrative Medicine, 2018,24(7):525-530. DOI: 10.1007/s11655-015-1973-0.
To study the pharmacokinetics of puerarin (PUE) in Gegen Qinlian Decoction (葛根芩连汤
GQD)
and the effects of PUE dosage variations on the pharmacokinetics of baicalin (BAL) in mice. GQD is composed of the concentrated granules of four Chinese herbs. Three dosages with different levels of PUE
including GQD
GQD co-administered with PUE
and GQD co-administration with two times the amount of PUE
were used to research the pharmacokinetics of PUE and BAL in mice. The indirect competitive enzyme-linked immunosorbent assay (icELISA) methods based on an anti PUE-monoclonal antibody (MAb)and BAL-MAb were employed to determine the concentration of PUE and BAL in mice blood. After the co-administration of GQD with PUE
the area under the curves (AUC0–14h) of PUE increased 2.8 times compared with GQD. At the dose of GQD co-administration at two times that of PUE
the (AUC0–14h) of PUE was almost equal to that of GQD co-administration of PUE
showing non-linear pharmacokinetics. The (AUC0–48h) of BAL showed a good dose-related increase of PUE (r=0.993) in the range from 100 to 300 mg/kg
indicating that PUE dramatically affects the absorption of BAL in mice. There was no significant difference in the other pharmacokinetic parameters
such as the first time of maximum concentration (Tmax)
the second Tmax
or the mean residence time. The icELISA methods were successfully applied to pharmacokinetic studies of PUE and BAL in GQD in mice. The dosage variability of PUE of the main ingredient in GQD affects its own pharmacokinetic characteristics and the absorption characteristics of BAL.
To study the pharmacokinetics of puerarin (PUE) in Gegen Qinlian Decoction (葛根芩连汤
GQD)
and the effects of PUE dosage variations on the pharmacokinetics of baicalin (BAL) in mice. GQD is composed of the concentrated granules of four Chinese herbs. Three dosages with different levels of PUE
including GQD
GQD co-administered with PUE
and GQD co-administration with two times the amount of PUE
were used to research the pharmacokinetics of PUE and BAL in mice. The indirect competitive enzyme-linked immunosorbent assay (icELISA) methods based on an anti PUE-monoclonal antibody (MAb)and BAL-MAb were employed to determine the concentration of PUE and BAL in mice blood. After the co-administration of GQD with PUE
the area under the curves (AUC0–14h) of PUE increased 2.8 times compared with GQD. At the dose of GQD co-administration at two times that of PUE
the (AUC0–14h) of PUE was almost equal to that of GQD co-administration of PUE
showing non-linear pharmacokinetics. The (AUC0–48h) of BAL showed a good dose-related increase of PUE (r=0.993) in the range from 100 to 300 mg/kg
indicating that PUE dramatically affects the absorption of BAL in mice. There was no significant difference in the other pharmacokinetic parameters
such as the first time of maximum concentration (Tmax)
the second Tmax
or the mean residence time. The icELISA methods were successfully applied to pharmacokinetic studies of PUE and BAL in GQD in mice. The dosage variability of PUE of the main ingredient in GQD affects its own pharmacokinetic characteristics and the absorption characteristics of BAL.
pharmacokineticsGegen Qinlian Decoctionindirect competitive enzyme-linked immunosorbent assayPuerarinBaicalinChinese Medicine
pharmacokineticsGegen Qinlian Decoctionindirect competitive enzyme-linked immunosorbent assayPuerarinBaicalinChinese Medicine
Yao D, Ding XS. Discussions in pharmacological action and the development in clinical application of puerarin. Chin J Clin Phamacol Ther (Chin) 2008;13:468–474.
Pang W, Lan XM, Wang CB. Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils. Chin J Integr Med 2012;18:283–287.
Wen M, Li X, Fu SY. New research progress in pharmacological activities of baicalin. J Shenyang Pharm Univ (Chin) 2008;25:158–162.
Wen YJ, Zhou YX, Zhang YS. A study on the dosage of Gegen Qinlian Decoction. J Liaoning Univ Tradit Chin Med (Chin) 2011;13:82–83.
Liu YZ, Zhang J, Wang YS. Liu A. Investigation of the dosage of Gegen Qinlian Decoction. Chin J Exp Tradit Med Formulae (Chin) 2010;16:216–218.
Gong HL, Tang WF, Wang J, Chen GY, Huang X. Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction in rats. Chin J Integr Med 2012;18:708–713.
Alatengqimuge Y, Yang XW, Zheng Y, Ma L, Lu W. LC analysis and pharmacokinetic study of pachymic acid after intravenous administration to rats. Chromatographia 2008;67:807–811.
Yin XB, Qu CH, Li ZX, Zhai YJ, Cao SL, Lin LF, et al. Simultaneous determination and pharmacokinetic study of polyphyllin I, polyphyllin II, polyphyllin VI and polyphyllin VII in beagle dog plasma after oral administration of Rhizoma Paridis extracts by LC-MS-MS. Biomed Chromatogr 2013;27:343–348.
Jahangiri S, Hatami M, Farhadi K, Bahram M. Hollowfiber- based LPME as a reliable sampling method for gas-chromatographic determination of pharmacokinetic parameters of valproic acid in rat plasma. Chromatographia 2013;76:663–669.
Spanakis M, Niopas I. GC-MS simultaneous determination of enalapril and enalaprilat in human plasma: application to a clinical pharmacokinetic study. Chromatographia 2010;72:957–962.
Ying XX, Wang F, Cheng ZZ, Zhang WJ, Li HB, Du Y, et al. Pharmacokinetics of vitexin-400-o-glucoside in rats after intravenous application. Eur J Drug Metab Pharmacokinet 2012;37:109–115.
Yang XM, Zhang XL, Chen YC, Liu F. LC Method for determination of Ginkgolic acids in mice plasma and its application to a pharmacokinetic study. Chromatographia 2009;69:593–596.
Montagna M, Visai L, Di Comite A, Iommiello V, Avanzini MA, Bloise N, et al. Development and validation of an enzyme linked immunosorbent assay for palivizumab serum determination. Int J Immunopathol Pharmacol 2013;26:503–510.
Zhao Y, Qu HH, Zhang GL, Li YF, Wang XQ, Wang QG. Study of the metabolic characteristics of geniposide in the different encephalic region of the SD Rats. Neurochem Res 2012;37:2272.
Chen HY, Zhuang HS, Yang GX, Ji XL. Development of a new polyclonal antibody for the determination of polychlorinated biphenyls indoor air by icELISA. Environ Sci Pollut Res 2013;20:2244–2251.
Zhao Y, Kong H, Sun Y, Feng HB, Zhang Y, Su X, et al. Assessment of baicalin in mouse blood by monoclonal antibody-based icElisa, Biomed Chromatogr 2014;28:1864–1868.
Qu HH, Zhang GL, Li YF, Sun H, Sun Y, Zhao Y, et al. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. J Chrom B Analyt Technol Biomed Life Sci 2014;953-954:120–125.
Qu HH, Zhao Y, Wang XQ, Yang AL, Li YF, Lu JQ, et al. Synthesis and identification of baicalin artificial antigen. J Beijing Univ Tradit Chin Med (Chin) 2010;33:606–609.
Su X, Qu HH, Zhao Y, Sun H, Sun Y, Wang XQ, et al. Establishment of quick enzyme-linked immunosorbent assay with monoclonal antibody against baicalin. Chin JPharm Anal 2013;33:946–949.
United States Food and Drug Administration Vol. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER) 2001;http://www.fda.gov/cder/guidance/4252fnl.htm
Zhai XJ, Qu HB, Shao Q, Cheng YY. Simultaneous quantification of puerarin and daidzein in rat plasma by high-performance liquid chromatography with post-column modification and fluorescence detection. Chromatographia 2007;66:43–47.
Wang CH, Cheng XM, He YQ, Mu DD, Chou GX, Wang ZT. Simultaneous determination of danshensu and puerarin in rat plasma by LC-MS-MS and its application to a pharmacokinetics and bioequivalence study after oral administration of Tongmai Dripping Pill and Tongmai Oral Solutions. Chromatographia 2009;70:95–102.
Qiu F, He ZG, Li HZ. HPLC analyses and pharmacokinetic studies of baicalin and oxymatrine in rabbits. Pharmazie 2003;58:616–619.
Ju WZ, Liu F, Wu T, Xia XY, Tan HS, Wang X, et al. Simultaneous determination of baicalin and chlorogenic acid in human plasma by UPLC-MS/MS. Acta Pharm Sin (Chin) 2007;42:1074–1077.
Ye J, Song X, Liu Z, Zhao X, Geng L, Bi K, et al. Development of an LC-MS method for determination of three active constituents of shuang-huang-lian injection in rat plasma and its application to the drug interaction study of shuang-huang-lian freeze-dried powder combined with levofloxacin injection. J Chromatogr B Analyt Technol Biomed Life Sci 2012;898:130–135.
Tan XM, Wu YP. Pharmacokinetics of puerarin in Gegen Qinlian Preparation in rabbit. Pharm Clin Chin Materia Med (Chin) 2006;22:1–2.
Wu YP, Tan XM, Xing XF. Pharmacokinetics of baicalin in Gegen Qinlian Decoction in dog. J South Med Univ (Chin) 2006;26:1239–1240.
Li XY, Zhang MF, Zhao Y, Wang X, Meng SN. Comparison of pharmacokinetics between different doses of puerarin in rats. J China Med Univ (Chin) 2009;38:885–887.
Cui SM, Zhao CS, He ZG. Study on absorption mechanism of puerarin using rat everted gut sac. Lishizhen Med Mater Med Res (Chin) 2008;19:1715–1716.
Tsai PL, Tsai TH. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. Planta Med 2004;70:1069–1074.
Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, et al. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000;52:1563–1568.
Liu TM, Jiang XH, Zhang MJ, Liao SJ, Chen Z. Absorption characteristics of baicalin an baicalein in rat small intestine. Chin Pharm J (Chin) 2006;41:1784–1787.
Zhang QY, Xu LH, Li BT, Luo H, Tang XL, Xu GL. Classified and interated pharmacokinetic study of multipe effective components contained in Gegen Qinlian Decoction. Chin J Clin Pharmacol Ther (Chin) 2011;16:51–56.
0
浏览量
0
Downloads
6
CSCD
关联资源
相关文章
相关作者
相关机构